Notice: This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CHFS vs. STRR, OM, IRIX, POCI, PXDT, NRXS, NDRA, CUTR, NXL, and GIAShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Star Equity (STRR), Outset Medical (OM), IRIDEX (IRIX), Precision Optics (POCI), Pixie Dust Technologies (PXDT), NeurAxis (NRXS), ENDRA Life Sciences (NDRA), Cutera (CUTR), Nexalin Technology (NXL), and GigCapital5 (GIA). Nuwellis vs. Star Equity Outset Medical IRIDEX Precision Optics Pixie Dust Technologies NeurAxis ENDRA Life Sciences Cutera Nexalin Technology GigCapital5 Nuwellis (NASDAQ:CHFS) and Star Equity (NASDAQ:STRR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings. Do analysts prefer CHFS or STRR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AStar Equity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals and insiders believe in CHFS or STRR? 65.1% of Nuwellis shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by company insiders. Comparatively, 28.8% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is CHFS or STRR more profitable? Star Equity has a net margin of -14.65% compared to Nuwellis' net margin of -254.26%. Star Equity's return on equity of -5.74% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-254.26% -173.61% -131.01% Star Equity -14.65%-5.74%-3.34% Which has more volatility and risk, CHFS or STRR? Nuwellis has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Which has higher valuation and earnings, CHFS or STRR? Star Equity has higher revenue and earnings than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$5.51M1.53-$18.11M-$279.28-0.01Star Equity$47.15M0.26$25.13M$6.500.60 Does the media favor CHFS or STRR? In the previous week, Star Equity's average media sentiment score of 1.87 beat Nuwellis' score of 0.00 indicating that Star Equity is being referred to more favorably in the news media. Company Overall Sentiment Nuwellis Neutral Star Equity Very Positive Does the MarketBeat Community believe in CHFS or STRR? Nuwellis received 321 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 69.53% of users gave Nuwellis an outperform vote. CompanyUnderperformOutperformNuwellisOutperform Votes32469.53% Underperform Votes14230.47% Star EquityOutperform Votes3100.00% Underperform VotesNo Votes SummaryStar Equity beats Nuwellis on 9 of the 14 factors compared between the two stocks. Ad DarwinDon’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.Click here to get your FREE report delivered instantly! Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.45M$3.71B$5.61B$8.48BDividend YieldN/A1.70%4.64%4.11%P/E Ratio-0.03123.70139.2720.33Price / Sales1.5349.991,234.8492.69Price / CashN/A78.3438.6333.59Price / Book0.113.964.884.66Net Income-$18.11M$99.67M$120.30M$227.46M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$1.40-3.4%N/A+39.4%$8.45M$5.51M-0.0366Gap UpSTRRStar Equity2.742 of 5 stars$3.91flatN/A-14.8%$12.40M$47.15M-1.40171Positive NewsOMOutset Medical2.8623 of 5 stars$0.61+1.7%$4.70+670.5%-83.8%$31.55M$116.43M-0.19520IRIXIRIDEX1.0505 of 5 stars$1.59+0.6%$2.00+25.8%-46.3%$25.84M$49.70M-2.41120Analyst ForecastPOCIPrecision Optics0.3007 of 5 stars$4.18-1.6%N/A-26.8%$25.81M$19.10M-8.5380PXDTPixie Dust Technologies2.4953 of 5 stars$1.67-1.8%$5.21+212.9%-81.6%$24.48M$993.02M0.0078Positive NewsNRXSNeurAxisN/A$2.92+3.5%N/A-9.1%$19.41M$2.27M-0.9919Gap UpNDRAENDRA Life Sciences3.0205 of 5 stars$0.21flat$20,000.00+9,569,278.0%-100.0%$15.17MN/A0.0020Gap DownCUTRCutera1.8985 of 5 stars$0.69-2.8%$5.33+669.6%-82.1%$14.27M$169.19M-0.10430News CoverageNXLNexalin Technology2.5644 of 5 stars$0.79-12.2%$3.00+278.8%+214.6%$8.39M$150,159.00-1.103News CoverageGap UpGIAGigCapital5N/A$0.61+3.2%N/A-94.4%$5.32MN/A0.002,021Gap Up Related Companies and Tools Related Companies: STRR Alternatives OM Alternatives IRIX Alternatives POCI Alternatives PXDT Alternatives NRXS Alternatives NDRA Alternatives CUTR Alternatives NXL Alternatives GIA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CHFS) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
